These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37981615)

  • 1. IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G.
    Jing R; Bai S; Zhang P; Ren H; Jia L; Li W; Zheng G
    Breast Cancer; 2024 Jan; 31(1):135-147. PubMed ID: 37981615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer.
    Ben Yahia H; Boujelbene N; Babay W; Ben Safta I; Dhouioui S; Zemni I; Ali Ayadi M; Charfi L; Ouzari HI; Rebmann V; Rizzo R; Mrad K; Driss M; Zidi I
    Hum Immunol; 2020 Jun; 81(6):305-313. PubMed ID: 32273131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction.
    Peng YP; Zhang JJ; Liang WB; Tu M; Lu ZP; Wei JS; Jiang KR; Gao WT; Wu JL; Xu ZK; Miao Y; Zhu Y
    BMC Cancer; 2014 Oct; 14():738. PubMed ID: 25274283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
    Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
    Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells.
    Ebokaiwe AP; Njoya EM; Sheng Y; Zhang Z; Li S; Zhou Z; Qiang Z; Peng T; Hussein AA; Zhang G; Lu X; Li L; Wang F
    Toxicol Appl Pharmacol; 2020 Oct; 404():115203. PubMed ID: 32822738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of indoximod upon stimulation with pro-inflammatory cytokines in triple-negative breast cancer cells.
    Guney Eskiler G; Bilir C
    Immunopharmacol Immunotoxicol; 2021 Oct; 43(5):554-561. PubMed ID: 34314307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoleamine 2,3-dioxygenase suppresses the cytotoxicity of 1 NK cells in response to ectopic endometrial stromal cells in endometriosis.
    Liu XT; Sun HT; Zhang ZF; Shi RX; Liu LB; Yu JJ; Zhou WJ; Gu CJ; Yang SL; Liu YK; Yang HL; Xu FX; Li MQ
    Reproduction; 2018 Oct; 156(5):397-404. PubMed ID: 30087159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
    Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
    Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation.
    Sato N; Saga Y; Mizukami H; Wang D; Takahashi S; Nonaka H; Fujiwara H; Takei Y; Machida S; Takikawa O; Ozawa K; Suzuki M
    Oncol Rep; 2012 Nov; 28(5):1574-8. PubMed ID: 22923135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
    López AS; Alegre E; LeMaoult J; Carosella E; González A
    Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
    Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
    Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer.
    Liu Z; Ding M; Qiu P; Pan K; Guo Q
    Front Immunol; 2023; 14():1200282. PubMed ID: 37520534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12 modulates the immunomodulatory properties of human periodontal ligament cells.
    Issaranggun Na Ayuthaya B; Satravaha P; Pavasant P
    J Periodontal Res; 2017 Jun; 52(3):546-555. PubMed ID: 27663623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytotoxic effects of indoleamine 2, 3-dioxygenase inhibitors on triple negative breast cancer cells upon tumor necrosis factor α stimulation.
    Bilir C; Eskiler GG; Bilir F
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S74-S80. PubMed ID: 37147986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer.
    Desroys du Roure P; Lajoie L; Mallavialle A; Alcaraz LB; Mansouri H; Fenou L; Garambois V; Rubio L; David T; Coenon L; Boissière-Michot F; Chateau MC; Ngo G; Jarlier M; Villalba M; Martineau P; Laurent-Matha V; Roger P; Guiu S; Chardès T; Gros L; Liaudet-Coopman E
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38290768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of indoleamine 2,3-dioxygenase suppresses NK cell activity and accelerates tumor growth.
    Kai S; Goto S; Tahara K; Sasaki A; Kawano K; Kitano S
    J Exp Ther Oncol; 2003; 3(6):336-45. PubMed ID: 14678522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.
    Roberti MP; Juliá EP; Rocca YS; Amat M; Bravo AI; Loza J; Coló F; Loza CM; Fabiano V; Maino M; Podhorzer A; Fainboim L; Barrio MM; Mordoh J; Levy EM
    Eur J Immunol; 2015 May; 45(5):1560-9. PubMed ID: 25726929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.
    Zheng G; Guo Z; Li W; Xi W; Zuo B; Zhang R; Wen W; Yang AG; Jia L
    Signal Transduct Target Ther; 2021 Jun; 6(1):236. PubMed ID: 34158475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
    Avril T; Saikali S; Vauleon E; Jary A; Hamlat A; De Tayrac M; Mosser J; Quillien V
    J Neuroimmunol; 2010 Aug; 225(1-2):22-33. PubMed ID: 20493562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.